Jan Basile to Randomized Controlled Trials as Topic
This is a "connection" page, showing publications Jan Basile has written about Randomized Controlled Trials as Topic.
Connection Strength
0.581
-
Lessons learned from the ONTARGET and TRANSCEND trials. Curr Atheroscler Rep. 2009 Sep; 11(5):371-6.
Score: 0.261
-
Recent clinical trials. J Am Soc Hypertens. 2014 Oct; 8(10):770-4; quiz 775-6.
Score: 0.092
-
All thiazide-like diuretics are not chlorthalidone: putting the ACCOMPLISH study into perspective. J Clin Hypertens (Greenwich). 2009 Jan; 11(1):5-10.
Score: 0.062
-
The importance of early antihypertensive efficacy: the role of angiotensin II receptor blocker therapy. J Hum Hypertens. 2006 Mar; 20(3):169-75.
Score: 0.051
-
Analysis of recent papers in hypertension. J Clin Hypertens (Greenwich). 2004 Feb; 6(2):96-101.
Score: 0.044
-
Beta-blockers for preventing sudden cardiac death. Postgrad Med. 2003 Dec; 114(6 Suppl Role):30-4.
Score: 0.044
-
Rationale and design for the blood pressure intervention of the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. Am J Cardiol. 2007 Jun 18; 99(12A):44i-55i.
Score: 0.014
-
Cardioprotection: the role of beta-blocker therapy. J Clin Hypertens (Greenwich). 2005 Jul; 7(7):409-16.
Score: 0.012